Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.21 | -24.02 |
| PEG Ratio (TTM) | 0.06 | -0.50 |
| P/S Ratio (TTM) | 0.40 | 0.66 |
| P/B Ratio (TTM) | 3.30 | 1.61 |
| P/FCF Ratio (TTM) | -4.98 | 0.84 |
| Price to 5YR AVG Earnings Ratio | 6.87 | 15.60 |
| Price to 5YR AVG FCF Ratio | 2.44 | 6.77 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.89% | -0.02% |
| ROE (TTM) | -43.31% | 4.30% |
| Net Profit Margin (TTM) | -10.15% | 4.19% |
| ROIC 5YR AVG | 37.18% | 6.05% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -10.26% | 225.74% | 116.44% |
| Revenue | -0.45% | 60.33% | 37.63% |
| Net Income | -13.31% | 231.51% | 119.22% |
| Cash Flow | -286.92% | 86.58% | 34.77% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.77 | 0.58 |
| Quick Ratio (TTM) | 1.84 | 0.55 |
| D/E Ratio (TTM) | 9.40 | 3.63 |
| Interest Coverage (TTM) | -0.02 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 0.29 | 0.56 |
| LTL to 5YR AVG FCF | 9.50 | 25.87 |
| Shares Outstanding Growth 5YR AVG | 2.50% | -0.28% |